武汉云克隆科技股份有限公司

S100钙结合蛋白A7(S100A7)多克隆抗体

Polyclonal Antibody to S100 Calcium Binding Protein A7 (S100A7)

S100-A7; PSOR1; S100A7c; Psoriasin 1

  • S100钙结合蛋白A7(S100A7)多克隆抗体产品包装(模拟)
  • S100钙结合蛋白A7(S100A7)多克隆抗体产品包装(模拟)
  • PAC035Bo01.jpgWB图
  • S100钙结合蛋白A7(S100A7)多克隆抗体Western Blot; Sample: Bovine Thymus lysate;
    Primary Ab: 1µg/ml Rabbit Anti-Bovine S100A7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • S100钙结合蛋白A7(S100A7)多克隆抗体Western Blot; Sample: Bovine Pancreas lysate;
    Primary Ab: 1µg/ml Rabbit Anti-Bovine S100A7 Antibody
    Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对S100A7的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别S100A7。

用法

免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Bos taurus; Bovine (Cattle，牛)应用(仅供研究使用，不用于临床诊断！)
RPC035Bo02S100钙结合蛋白A7(S100A7)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APC035Bo61S100钙结合蛋白A7(S100A7)活性蛋白Cell culture; Activity Assays.
RPC035Bo01S100钙结合蛋白A7(S100A7)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPC035Bo61S100钙结合蛋白A7(S100A7)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC035Bo02S100钙结合蛋白A7(S100A7)多克隆抗体WB
PAC035Bo01S100钙结合蛋白A7(S100A7)多克隆抗体WB; IHC; ICC; IP.
SEC035BoS100钙结合蛋白A7(S100A7)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
KSC035Bo01S100钙结合蛋白A7(S100A7)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It(ELISA Kit) Yourself"

参考文献

杂志参考文献
Archives of Dermatological ResearchSerum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters[SpringerLink: t07u24t43r357l15]
J Proteome ResProteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC–MS Approach[PubMed: 25807139]
Exp DermatolS100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL-6 secretion through IκB/NF-κB signaling[Pubmed:27060579]
Experimental DermatologyS100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL‐6 secretion through IκB/NF‐κB signalling[pubmed:27060579]
Experiental And Therapeutic MedicinePlasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription[pubmed:28672924]
Scientific ReportsThe psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.[pubmed:29142248]
Journal of the European Academy of Dermatology and VenereologyA potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis[Pubmed:28681537]
Scientific ReportsMeasurements of AMPs in stratum corneum of atopic dermatitis and healthy skin–tape stripping technique[Pubmed:29374283]
Neuroscience BulletinComprehensive proteomic profiling of patients' tears identifies potential biomarkers for the traumatic vegetative state[Pubmed:30019218]
Journal of ProteomicsSalivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection[Pubmed: 31706945]
Mediators of InflammationAlarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris[]